Clinical Trials

Showing trials with last updates posted in 2024.

NCT03059992 | COMPLETED | PHASE3
233 participants

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Study Type:
INTERVENTIONAL
Last Updated:
2024-11-20
Start Date:
2017-04-01
Completion:
2023-08-25
Conditions
  • Invasive Candidiasis
  • Mucocutaneous Candidiasis
  • Coccidioidomycosis
  • Histoplasmosis
  • Blastomycosis
  • Chronic Pulmonary Aspergillosis
  • Allergic Bronchopulmonary Aspergillosis
  • Invasive Pulmonary Aspergillosis
  • Recurrent Vulvovaginal Candidiasis
  • Other Emerging Fungi
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page